|
|
 |
 |
|
|
 |
 |
| Watch our online videos and learn more
about our legal services. |
View Now |
|
 |
|
|
 |
|
|
|
|
|
|
Zyprexa
|
Zyprexa (Olanzapine) was approved by the Food and Drug
Administration (FDA) in 1996 for the treatment of
schizophrenia and acute bipolar mania. In March of
2004, the FDA and Eli Lilly and Company informed
healthcare professionals that the Zyprexa label
warnings would include the description of increased
risk of hyperglycemia and diabetes in patients who
take Zyprexa. In fact, the FDA has asked all
manufacturers of atypical antipsychotic medications
to add the Warning statement to labeling.
At Keel O'Malley Tunstall, L.L.P. L.L.P., we are dedicated to holding
pharmaceutical manufacturers who make unsafe or
mislabeled drugs accountable and liable for their
actions. Our attorneys help improve the lives of our
clients by fighting for their right to fair
compensation. We have successfully handled dangerous
drug cases in North Carolina.
Zyprexa is a thienobenzodiazepine and is considered
an "atypical" antipsychotic medication that is used
to treat schizophrenia. It is thought that Zyprexa
works by decreasing the effects of two chemical
messengers in the brain, serotonin and dopamine. In
a 2001, the Journal of Clinical Psychiatry stated
that the FDA had received numerous case reports
linking Zyprexa use to diabetes. Many patients were
newly diagnosed with hyperglycemia and some had
developed problems within a week to six months of
taking the drug. Diabetic ketoacidosis is another
life-threatening complication that has been linked
to Zyprexa. Four separate medical agencies have
issued a warning that people being treated for
schizophrenia, manic depression, autism, dementia
and other psychiatric disorders should be closely
monitored for symptoms of developing diabetes,
obesity and/or high cholesterol. In addition to
Zyprexa, physicians were warned that patients taking
Abilify, Clozaril, Geodon, Resperdal, and Seroquel
should be monitored for signs of developing of heart
disease. While not approved for use in elderly
dementia patients, physicians still prescribe the
drug on an "off-label" basis. Off-label use refers
to the practice of marketing or prescribing a drug
in a different dose, for a longer period of time, or
for a different medical condition than approved by
the FDA. Eli Lilly and Company has notified doctors
and psychiatrists that elderly patients with
dementia face an increased risk of stroke with
Zyprexa treatment.
Despite a continuing civil investigation by the U.S.
Attorney for the Eastern District of Pennsylvania
into Eli Lilly's marketing and promotion of Zyprexa,
the drug represents about one-third of Eli Lilly's
4.3 billion in sales last year. As investigations
continue and Eli Lilly's profit margins grow,
vulnerable consumers continue to suffer from health
risks associated with the drug.
At Keel O'Malley Tunstall, L.L.P. L.L.P., we believe that consumers
have the right to medication that is safe when taken
as directed. If you or a family member have been
injured by Zyprexa or have lost a family member
because of this medication, please contact us today
at (252) 823-2266 or toll free at (800) 755-1987, or
submit an online
questionnaire. Our team of attorneys, legal
assistants, a professional investigator and a
registered nurse will review and analyze your case.
We will discuss the situation with you in an initial
consultation that is always free and will work for
you on a contingency fee basis. In many cases, a
lawsuit must be filed within a limited timeframe
known as a statute of limitations.
<< Back to
Practice AreasEmail this Page |
Print this Page
|
|
|
|
|
|
|
Copyright © 2005 Keel O'Malley Tunstall, L.L.P.All Rights Reserved.
Disclaimer
Medical Malpractice, Personal Injury, Car Accident Lawyer, Truck Accidents, Social Security Disability, Workers Compensation, Prescription Drug Claims, Crestor, Vioxx, Zyprexa, Improperly Filled Prescriptions, Products Liability, Nursing Home Neglect
Serving Eastern NC - Tarboro, Greenville, Rocky Mount, Williamston, Henderson, Roanoke Rapids, Washington, Nashville,
Edgecombe, Wake County
|
|
|
